Delivery Order 75N98019D00058-75N91022F00002
Award Date
3/8/22
Potential Completion Date
3/31/24
Potential Value
$547K
Federal Agency
National Cancer Institute
Awardee
Societal Cdmo San Diego, LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
Q517 - Pharmacy Services
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
2
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Societal Cdmo San Diego, LLC was awarded a $78,600 firm fixed price delivery order against the National Cancer Institute Cooperative Agreement for Cancer Target Discovery and Preclinical Validation Studies master indefinite-delivery/indefinite-quantity contract by the Department of Health and Human Services' National Institutes of Health. Under the delivery order, Societal Cdmo San Diego, LLC will provide metarestin storage and stability testing services for the National Cancer Institute,...
This is a delivery order awarded by the National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to Societal CDMO San Diego, LLC, a small disadvantaged business contract development and manufacturing organization (CDMO). The $494,300 firm-fixed-price task order is for dosage form development, manufacture, and stability studies of the investigational compound metarrestin (ML246) under the larger "CRO Support for NCATS Drug Product Development,...
This is a $249,950.42 firm fixed-price delivery order awarded to Societal CDMO San Diego, LLC (doing business as Irisys Inc.) by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The contract is for the production of a current Good Manufacturing Practices (cGMP) batch of Triapine injection, a novel anticancer drug. This order was placed under the $45 million Drug Formulation and Manufacturing...
This is a $17,542 Cost Plus Fixed Fee delivery order awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to Societal CDMO San Diego, LLC (doing business as Irisys Inc.), a self-certified small disadvantaged business. The contract is for the production and evaluation of the stability of tetrathiomolibdate capsules in a non-GMP study. This award is part of Societal CDMO San Diego's work...
This is a $100,393.00 cost-plus-fixed-fee delivery order awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services (HHS), to Societal CDMO San Diego, LLC (dba Irisys Inc.), a self-certified small disadvantaged business and limited liability company. The purpose of this task order is to produce one batch of 10,000 endoxifen capsules, 40 mg per capsule, over the period of performance from January 30, 2020 to June 29, 2020. This contract is not set...
The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $711,750.00 Firm Fixed Price Delivery Order contract to Societal CDMO San Diego, LLC (doing business as Irisys Inc.) for Metarrestin cGMP manufacturing and stability testing services. This contract is under the NCATS Drug Product Development Studies 2017-2022 indefinite delivery, indefinite quantity (IDIQ) contract vehicle. Societal CDMO is a self-certified small disadvantaged...
This $136,500 firm fixed-price delivery order was awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services (HHS), to Societal CDMO San Diego, LLC (doing business as Irisys Inc.). The contract is for the production of 2,500 vials of Cooper Histindinate, a pharmaceutical product likely used in cancer research and development. Societal CDMO San Diego is a small disadvantaged business contract development and manufacturing organization that...
This federal contract award was issued by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS), to Societal CDMO San Diego, LLC (doing business as Irisys Inc.), a self-certified small disadvantaged business and contract development and manufacturing organization (CDMO). The $77,283 task order is for the manufacture of 4-thio-2-deoxycytidine capsules, which are likely being developed for use in...
This federal contract award is for the production of 0.25mg of Azatdc and Tdcyd capsules, awarded to Societal Cdmo San Diego, LLC (doing business as Irisys Inc.), a self-certified small disadvantaged business. The contract, valued at $66,182.00, was issued by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute. It is a delivery order under the Drug Formulation and Manufacturing Contracts 2019 Indefinite Delivery, Indefinite Quantity...
This is a federal contract award from the National Cancer Institute (NCI), a component of the Department of Health and Human Services (HHS), to Societal CDMO San Diego, LLC, doing business as Irisys Inc. The $60,424 cost-plus-fixed-fee contract is for the manufacture of a 10 mg strength capsule formulation of the drug 4-thio-2-deoxycytidine under Good Manufacturing Practices (GMP). This contract supports the NCI's efforts in the manufacture of oral and topical dosage forms for investigational...